Apimeds Pharmaceuticals US, Inc. - 8-K Filing
Apimeds Pharmaceuticals executed a one-for-ten reverse stock split and reduced common stock par value to $0.001 per share effective July 24, 2026. (Items: 3.03 Material Modification to Rights of Security Holders, 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, 9.01 Financial Statements and Exhibits)
Tickers: $APUS